Pfizer COVID-19 vaccine not ready before Election Day

Pfizer said on Friday it could file for U.S. authorization of the COVID-19 vaccine it is developing with German partner BioNTech as early as late November, suggesting that it's possible a vaccine could be available in the United States this year, but that timeline makes it unlikely a vaccine will be available before the U.S. election as President Donald Trump has promised. Subscribe: http://smarturl.it/reuterssubscribe Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled. Get the latest news on: http://reuters.com/ Follow Reuters on Facebook:   / reuters   Follow Reuters on Twitter:   / reuters   Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en